Matthew R. Thau, MD

NPI 1922457613ActiveIndividual· Internal Medicine, Critical Care Medicine· Atlanta, GA

Internal Medicine, Critical Care Medicine (MD) in Atlanta, Georgia, trained at University of South Florida College of Medicine (class of 2016). Their prescriptions cost Medicare Part D more than their services did: $144,285 for 99 claims, against $54,624 paid for services in 2024. Genzyme Corporation reported $18.07 in payments in 2025, mostly food and beverage.

Overview

NPI	1922457613
Status	Active
Entity type	Individual
Credential	MD
Sole proprietor	Yes
NPI issued	Jun 3, 2016
Last updated in NPPES	Jun 26, 2025
Certified by provider	Jun 26, 2025

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Critical Care Medicine Primary	207RC0200X	103965	GA
Internal Medicine	207R00000X	103965	GA
Internal Medicine, Pulmonary Disease	207RP1001X	103965	GA

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Pulmonary Disease (GA); Practitioner - Critical Care (Intensivists) (TX)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	150
Services billed	452 across 30 procedure codes
Paid by Medicare	$54,624

Part D prescriptions in 2024

Prescriptions (claims)	99 · 141 30-day fills
Patients	23
Total drug cost	$144,285
Generic share	65% of claims

Medicare sources and data years

Education and affiliations

Medical school	University of South Florida College of Medicine
Graduation year	2016
Medicare specialty	Pulmonary Disease
Secondary specialties	Critical Care (Intensivists), Internal Medicine